Windham Capital Partners LLCFirm match from fund name (lower confidence)
Windham Life Sciences Partners IV, L.P.
Open: first sale Oct 2023, per Form D (fund age approximates vintage)
- Vintage
- 2023
- Fund size
- $30.78M to $150M (Form D)
- Stages
- Not stated
- Sectors
- Healthtech
- Regions
- Not stated
01 · Thesis
Windham Capital Partners invests in HealthTech companies, focusing on healthcare technologies that improve outcomes and lower costs. It backs people solving difficult problems and building category-defining products in healthcare, with companies that address large unmet needs in large markets.Inferred from the firm's website
02 · Initial check
$308K to $2.5M (estimated from fund size)
Estimated from Form D: $30.78M sold of a $150M target
03 · Who to approach
Named on this fund's Form D
- Adam Fine, General Partner & CEO
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideWindham Capital Partners invests in HealthTech companies, focusing on healthcare technologies that improve outcomes and lower costs.
Investing in life-saving, game-changing HealthTech
https://www.windhamcap.com/
06 · Sources
Last verified: Oct 28, 2026